Merus to present at the 36th annual J.P. Morgan Healthcare conference

UTRECHT, The Netherlands, Jan. 02, 2018 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton Logtenberg, Ph.D., Chief Executive Officer, will present a company overview at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018, at 9:30 a.m. PT.

A live webcast of the presentation will be available on the Investors page of the Company’s website, An archived presentation will be available for 90 days.


Kimberly Minarovich
+1 646 368 8014

Eliza Schleifstein
+1 973 361 1546

Merus N.V.